- Home
- RCUS vs PSFE Comparison
RCUS vs PSFE Comparison
Compare RCUS & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- PSFE
- Stock Information
- Founded
- RCUS 2015
- PSFE 1996
- Country
- RCUS United States
- PSFE United Kingdom
- Employees
- RCUS N/A
- PSFE N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- PSFE Business Services
- Sector
- RCUS Health Care
- PSFE Consumer Discretionary
- Exchange
- RCUS Nasdaq
- PSFE Nasdaq
- Market Cap
- RCUS 727.1M
- PSFE 856.2M
- IPO Year
- RCUS 2018
- PSFE N/A
- Fundamental
- Price
- RCUS $8.28
- PSFE $15.41
- Analyst Decision
- RCUS Buy
- PSFE Sell
- Analyst Count
- RCUS 11
- PSFE 4
- Target Price
- RCUS $25.33
- PSFE $17.38
- AVG Volume (30 Days)
- RCUS 1.2M
- PSFE 230.5K
- Earning Date
- RCUS 05-06-2025
- PSFE 05-13-2025
- Dividend Yield
- RCUS N/A
- PSFE N/A
- EPS Growth
- RCUS N/A
- PSFE N/A
- EPS
- RCUS N/A
- PSFE 0.36
- Revenue
- RCUS $141,000,000.00
- PSFE $1,704,835,000.00
- Revenue This Year
- RCUS N/A
- PSFE $2.83
- Revenue Next Year
- RCUS $25.77
- PSFE $6.27
- P/E Ratio
- RCUS N/A
- PSFE $42.97
- Revenue Growth
- RCUS N/A
- PSFE 6.48
- 52 Week Low
- RCUS $6.50
- PSFE $13.01
- 52 Week High
- RCUS $18.98
- PSFE $26.25
- Technical
- Relative Strength Index (RSI)
- RCUS 48.63
- PSFE 50.87
- Support Level
- RCUS $7.06
- PSFE $14.78
- Resistance Level
- RCUS $9.35
- PSFE $16.07
- Average True Range (ATR)
- RCUS 0.55
- PSFE 0.54
- MACD
- RCUS 0.06
- PSFE 0.11
- Stochastic Oscillator
- RCUS 53.28
- PSFE 72.84
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.